Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)

Authors :: Matthew M.Y. Lee
Keith A. Gillis
Katriona J.M. Brooksbank
Sarah Allwood-Spiers
Pauline Hall Barrientos
Kirsty Wetherall
Giles Roditi
Bashair AlHummiany
Colin Berry
Ross T. Campbell
Victor Chong
Liz Coyle
Kieran F. Docherty
John G. Dreisbach
Bernd Kuehn
Catherine Labinjoh
Ninian N. Lang
Vera Lennie
Kenneth Mangion
Alex McConnachie
Clare L. Murphy
Colin J. Petrie
John R. Petrie
Kanishka Sharma
Steven Sourbron
Iain A. Speirits
Joyce Thompson
Paul Welsh
Rosemary Woodward
Ann Wright
Aleksandra Radjenovic
John J.V. McMurray
Pardeep S. Jhund
Mark C. Petrie
Naveed Sattar
Patrick B. Mark
Source :: Circulation. 146(4)
Publication Year :: 2022
Abstract: No abstract available.

Subjects :: Heart Failure
Prediabetic State
Diabetes Mellitus, Type 2
Glucosides
Physiology (medical)
Humans
Stroke Volume
Benzhydryl Compounds
Cardiology and Cardiovascular Medicine
Kidney

Tools